Skip to main content
. 2014 May 27;32(31):3917–3926. doi: 10.1016/j.vaccine.2014.05.052

Fig. 2.

Fig. 2

CVB3-specific antibody responses elicited by intranasal immunization with various groups of VSV-VP1, VSV–GFP, chito-pcDNA3.1-VP1, chito-pcDNA3.1 or PBS administration. Mice were immunized with four doses of various DNA vaccines at 2 weeks intervals, while the two VSV-based vaccine groups were immunized only with a single dose of 106 PFU viruses. The levels of CVB3-specific serum IgG(A) and fecal sIgA (B) at 2-week intervals. The results are expressed as the mean ± SD from three separate experiments.